Startups
By developing novel and affordable vaccines for all populations worldwide we're addressing health inequalities and empowering people to live healthy lives
Inventprise is a mission driven vaccine manufacturing company developing vaccines that have shown a more robust and broader spectrum of protection than currently marketed conjugated vaccines.
Our lead vaccine candidate is a 25-valent pneumococcal conjugate vaccine (PCV) funded by the Bill and Melinda Gates Foundation (>$100M) and aimed at large-scale supply to Low-Middle Income Countries. Additionally, we have a robust pipeline of vaccines and vaccine technologies, that have both viral and bacterial applications.
Inventprise was founded in 2012, and is led by founder and Executive Chairman, Subhash Kapre PhD, former SVP and Corporate Officer of Serum Institute of India and Chief Executive Officer, Yves Leurquin, former general manager of Takeda Vaccines, Europe.
Inventprise is based in Redmond, Washington, we have over 100,000 square feet of recently built, state-of-the-art facilities that have the capacity for large scale volume (>150M annual doses). With over 100 employees mostly exceptionally qualified industry scientists, and manufacturing professionals, Inventprise has created a large and dynamic presence in the Washington State Life Sciences environment.
Inventprise is a mission driven vaccine manufacturing company developing vaccines that have shown a more robust and broader spectrum of protection than currently marketed conjugated vaccines.
Our lead vaccine candidate is a 25-valent pneumococcal conjugate vaccine (PCV) funded by the Bill and Melinda Gates Foundation (>$100M) and aimed at large-scale supply to Low-Middle Income Countries. Additionally, we have a robust pipeline of vaccines and vaccine technologies, that have both viral and bacterial applications.
Inventprise was founded in 2012, and is led by founder and Executive Chairman, Subhash Kapre PhD, former SVP and Corporate Officer of Serum Institute of India and Chief Executive Officer, Yves Leurquin, former general manager of Takeda Vaccines, Europe.
Inventprise is based in Redmond, Washington, we have over 100,000 square feet of recently built, state-of-the-art facilities that have the capacity for large scale volume (>150M annual doses). With over 100 employees mostly exceptionally qualified industry scientists, and manufacturing professionals, Inventprise has created a large and dynamic presence in the Washington State Life Sciences environment.
Overview
Location
United States, Washington, Redmond
Employees
51-200
Founded date
2012
Mentions in press and media 2
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Nov 10, 2021 | Seattle-area startup Inventprise gets backing from Gates Foundation for pneumonia shot | A worker at an Inventprise manufacturing facility. (Inventprise Photo) Inventprise has been slowly growing in Redmond, Wash., expanding into four research and manufacturing facilities to support early development of a host of vaccines since... |
Reviews 0
FAQ about Inventprise LLC
When was Inventprise LLC founded?
Inventprise LLC was founded in 2012.
What has the press written about Inventprise LLC?
Parsers VC has collected 2 articles mentioning Inventprise LLC, among them “Seattle-area startup Inventprise gets backing from Gates Foundation for pneumonia shot” (Nov 10, 2021).
Is Inventprise LLC still active?
Yes, Inventprise LLC is active; its latest activity on Parsers VC dates from Oct 8, 2024.